These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 19926271

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study.
    Roux P, Carrieri MP, Villes V, Dellamonica P, Poizot-Martin I, Ravaux I, Spire B, MANIF2000 cohort study group.
    Addiction; 2008 Nov; 103(11):1828-36. PubMed ID: 18778390
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Exposure to opioid maintenance treatment reduces long-term mortality.
    Gibson A, Degenhardt L, Mattick RP, Ali R, White J, O'Brien S.
    Addiction; 2008 Mar; 103(3):462-8. PubMed ID: 18190664
    [Abstract] [Full Text] [Related]

  • 7. Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS.
    Lawrinson P, Ali R, Buavirat A, Chiamwongpaet S, Dvoryak S, Habrat B, Jie S, Mardiati R, Mokri A, Moskalewicz J, Newcombe D, Poznyak V, Subata E, Uchtenhagen A, Utami DS, Vial R, Zhao C.
    Addiction; 2008 Sep; 103(9):1484-92. PubMed ID: 18636999
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. One-year mortality rates of patients receiving methadone and buprenorphine maintenance therapy: a nationally representative cohort study in 2694 patients.
    Soyka M, Apelt SM, Lieb M, Wittchen HU.
    J Clin Psychopharmacol; 2006 Dec; 26(6):657-60. PubMed ID: 17110826
    [Abstract] [Full Text] [Related]

  • 12. Buprenorphine replacement therapy: a confirmed benefit.
    Prescrire Int; 2006 Apr; 15(82):64-70. PubMed ID: 16604748
    [Abstract] [Full Text] [Related]

  • 13. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia.
    Winstock AR, Lea T, Sheridan J.
    Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment.
    Pinto H, Maskrey V, Swift L, Rumball D, Wagle A, Holland R.
    J Subst Abuse Treat; 2010 Dec; 39(4):340-52. PubMed ID: 20817384
    [Abstract] [Full Text] [Related]

  • 16. Retention in methadone maintenance drug treatment for prescription-type opioid primary users compared to heroin users.
    Banta-Green CJ, Maynard C, Koepsell TD, Wells EA, Donovan DM.
    Addiction; 2009 May; 104(5):775-83. PubMed ID: 19344438
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Barriers and facilitators to primary care or human immunodeficiency virus clinics providing methadone or buprenorphine for the management of opioid dependence.
    Turner BJ, Laine C, Lin YT, Lynch K.
    Arch Intern Med; 2009 May; 165(15):1769-76. PubMed ID: 16087826
    [Abstract] [Full Text] [Related]

  • 19. Colocating buprenorphine with methadone maintenance and outpatient chemical dependency services.
    Whitley SD, Kunins HV, Arnsten JH, Gourevitch MN.
    J Subst Abuse Treat; 2007 Jul; 33(1):85-90. PubMed ID: 17588493
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.